Skip to main content

Table 1 The demographic and clinical characteristics of eligible TMT and NAC + RC patients before and after the propensity score match

From: Comparison of trimodality therapy and neoadjuvant chemotherapy combined with radical cystectomy for the survival of muscle-invasive bladder cancer: a population-based analysis

Variables

Data before PSM

Data after PSM

 

TMT

N = 822

NAC + RC

N = 353

P

TMT

N = 303

NAC + RC

N = 303

P

Age

      

 < 68 years

198 (24.1)

217 (61.5)

< 0.001

157 (51.8)

167 (55.1)

0.464

 ≥ 68 years

624 (75.9)

136 (38.5)

 

146 (48.2)

136 (44.9)

 

Sex

      

 Male

619 (75.3)

261 (73.9)

0.673

233 (76.9)

221 (72.9)

0.303

 Female

203 (24.7)

92 (26.1)

 

70 (23.1)

82 (27.1)

 

Race

      

 White

712 (86.6)

315 (89.2)

0.104

261 (86.1)

271 (89.4)

0.117

 Black

65 (7.9)

16 (4.5)

 

24 (7.9)

12 (4.0)

 

 Other/Unknown

45 (5.5)

22 (6.2)

 

18 (5.9)

20 (6.6)

 

Marital status

      

 Married

459 (55.8)

224 (63.5)

0.018

182 (60.1)

192 (63.4)

0.452

 Unmarried/unknown

363 (44.2)

129 (36.5)

 

121 (39.9)

111 (36.6)

 

Grade

      

 I/II

19 (2.3)

7 (2.0)

0.939

4 (1.3)

7 (2.3)

0.659

 III/IV

742 (90.3)

320 (90.7)

 

278 (91.7)

275 (90.8)

 

 Unknown

61 (7.4)

26 (7.4)

 

21 (6.9)

21 (6.9)

 

T stage

      

 T2

726 (88.3)

232 (65.7)

< 0.001

222 (73.3)

232 (76.6)

0.257

 T3–4a

62 (7.5)

93 (26.3)

 

56 (18.4)

56 (18.4)

 

 Unknown

34 (4.1)

28 (7.9)

 

25 (8.3)

15 (5.0)

 
  1. TMT: trimodality therapy; NAC: neoadjuvant chemotherapy; RC: radical cystectomy